Keytruda for Hepatocellular Carcinoma User Reviews
- Jan...
- Taken for less than 1 month
- September 18, 2020
"One treatment of Keytruda finished off my husband within 3 months. The doctors tried steroids to stop Keytruda effects, but nothing worked. The doctor did not even type his liver cancer before giving Keytruda."
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Are you taking this medicine?
Your review helps others make informed decisions.Learn more about Hepatocellular Carcinoma
Care guides
Symptoms and treatments
More about Keytruda (pembrolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (257)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"I did five treatments with Keytruda, and my tumors were stable up until the 5th, where they doubled in size, so I immediately stopped Keytruda. Now I am currently taking Lenvima 10 mg pill once per day, we'll see how that works out. Not very hopeful, though, seems like I'm running out of options."